Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Nero who wrote (710)	5/5/1998 3:51:00 PM
From: Tim Cruise	Read Replies (2) \| Respond to of 2135

Nero, I feel your pain as I learned this lesson once with IOM. However, I am curious as to what prompted your purchase? Where you watching business news? Broker call? It is hard for me to keep my emotions in check, and I understand impulse buying. I like your train of thought to just hold. Why not sell some calls whilst the volatility remains and recoup some premium? Good luck, Tim

To: Nero who wrote (710)	5/5/1998 4:03:00 PM
From: Hiram Walker	Respond to of 2135

Nero, wow the teens? Whats the overly optimistic view from? Wow, if its in the teens by 2002,I will be certainly surprised. If it exists at all by 2002,it will be a grand success. How many biotechs I have seen go under,and how many are still around? Hell, maybe ENMD can buy KTEL and sell records of Donny Osmond singing"I been down since I began to fall,if it weren't for bad luck,would have no luck at all". Good luck man, you may need it. Hiram

To: Nero who wrote (710)	5/6/1998 9:43:00 AM
From: PAL	Read Replies (1) \| Respond to of 2135

I am sorry for your loss especially in the IRA account since you cannot deduct the loss. Since yesterday I have been posting to get out while you can because this stock is coming back to earth. Do not gamble with IRA money hoping that it will bounce back in 2002. This biotech company is very risky. There is nio guarantee that the two drugs will be effective on humans. Additionally there are several other firms that do research for cancer with easier applications.